Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sifrol® (Pramipexole) Impact on RLS Related Quality of Life: A 12-weeks Observational Study in Patients With Primary RLS

NCT00539461 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00539461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00539461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sifrol® (Pramipexole) Impact on RLS Related Quality of Life: A 12-weeks Observational Study in Patients With Primary RLS
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
February 28, 2007
Completion date
Not reported
Enrollment
2,023 (actual)
Sites
317

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome